15 min listen
Examining Cannabis Stocks Earnings: CGC, CRON, MSOS
FromSchwab Network
ratings:
Length:
7 minutes
Released:
Aug 6, 2021
Format:
Podcast episode
Description
Alan Brochstein, Managing Partner at New Cannabis Ventures and Principal at 420 Investor, examines cannabis stocks. He discusses what investors have learned from Canopy Growth’s (CGC) earnings. He talks about Cronos’ (CRON) 2Q revenue which came in at $15.60M versus an estimated $18.08M. He also mentions AdvisorShares Trust Pure US Cannabis ETF (MSOS). Tune in to find out more.
Released:
Aug 6, 2021
Format:
Podcast episode
Titles in the series (100)
Kevin O'Leary's Outlook for Tech, Airlines, and the Overall Market by Schwab Network